Tower Research Capital (TRC)’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-771
| Closed | -$7.07K | – | 5486 |
|
|
2025
Q1 | $7.07K | Buy |
771
+579
| +302% | +$3.63K | ﹤0.01% | 3984 |
|
|
2024
Q4 | $1.28K | Sell |
192
-360
| -65% | -$3.17K | ﹤0.01% | 5055 |
|
|
2024
Q3 | $5.54K | Sell |
552
-1,020
| -65% | -$14.9K | ﹤0.01% | 4252 |
|
|
2024
Q2 | $24.5K | Buy |
1,572
+1,208
| +332% | +$20.2K | ﹤0.01% | 3639 |
|
|
2024
Q1 | $7.98K | Sell |
364
-226
| -38% | -$5.02K | ﹤0.01% | 4101 |
|
|
2023
Q4 | $11.4K | Sell |
590
-37
| -6% | -$675 | ﹤0.01% | 4133 |
|
|
2023
Q3 | $11.6K | Buy |
627
+263
| +72% | +$4.73K | ﹤0.01% | 3977 |
|
|
2023
Q2 | $6.72K | Sell |
364
-72
| -17% | -$1.7K | ﹤0.01% | 4669 |
|
|
2023
Q1 | $13K | Buy |
436
+236
| +118% | +$6.28K | ﹤0.01% | 3993 |
|
|
2022
Q4 | $6K | Sell |
200
-301
| -60% | -$11.4K | ﹤0.01% | 4745 |
|
|
2022
Q3 | $28K | Buy |
501
+323
| +181% | +$17.7K | ﹤0.01% | 3662 |
|
|
2022
Q2 | $10K | Sell |
178
-1,344
| -88% | -$49.4K | ﹤0.01% | 4470 |
|
|
2022
Q1 | $57K | Buy |
1,522
+1,305
| +601% | +$46.6K | ﹤0.01% | 2629 |
|
|
2021
Q4 | $5K | Buy |
217
+95
| +78% | +$3.18K | ﹤0.01% | 5178 |
|
|
2021
Q3 | $5K | Sell |
122
-274
| -69% | -$11.5K | ﹤0.01% | 4874 |
|
|
2021
Q2 | $18K | Buy |
396
+101
| +34% | +$5.16K | ﹤0.01% | 4001 |
|
|
2021
Q1 | $16K | Buy |
295
+17
| +6% | +$1.03K | ﹤0.01% | 4057 |
|
|
2020
Q4 | $17K | Sell |
278
-1,468
| -84% | -$89.9K | ﹤0.01% | 3972 |
|
|
2020
Q3 | $102K | Buy |
1,746
+1,370
| +364% | +$101K | ﹤0.01% | 3135 |
|
|
2020
Q2 | $42K | Buy |
376
+369
| +5,271% | +$26.3K | ﹤0.01% | 3185 |
|
|
2020
Q1 | $0 | Sell |
7
-41
| -85% | -$4.13K | ﹤0.01% | 3649 |
|
|
2019
Q4 | $7K | Sell |
48
-1,066
| -96% | -$138K | ﹤0.01% | 2536 |
|
|
2019
Q3 | $117K | Buy |
+1,114
| New | +$111K | 0.01% | 1264 |
|
|
2019
Q2 | – | Sell |
-2
| Closed | – | – | 4109 |
|
|
2019
Q1 | $0 | Sell |
2
-151
| -99% | -$17.5K | ﹤0.01% | 4151 |
|
|
2018
Q4 | $14K | Buy |
153
+106
| +226% | +$15.1K | ﹤0.01% | 2216 |
|
|
2018
Q3 | $9K | Buy |
47
+33
| +236% | +$9.41K | ﹤0.01% | 2831 |
|
|
2018
Q2 | $6K | Sell |
14
-55
| -80% | -$18.5K | ﹤0.01% | 3010 |
|
|
2018
Q1 | $21K | Buy |
69
+63
| +1,050% | +$17.5K | ﹤0.01% | 2147 |
|
|
2017
Q4 | $2K | Buy |
+6
| New | +$1.69K | ﹤0.01% | 3230 |
|
Tower Research Capital (TRC)'s OPTN Position: Q2 2025 in Review
Tower Research Capital (TRC) sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 771 shares — an estimated $7.07K sold.
Tower Research Capital (TRC) first reported a position in OPTN in Q4 2017 and held it in 29 quarters. The position peaked at $117K in Q3 2019. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- Tower Research Capital (TRC) reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- Tower Research Capital (TRC) sold 771 OptiNose shares in Q2 2025, an estimated $7.07K.
- Tower Research Capital (TRC) first reported a position in OptiNose in Q4 2017 and held it in 29 quarters.
- Tower Research Capital (TRC)'s OptiNose position peaked at $117K in Q3 2019.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.